CAT and Parkinson disease: Treatment with SMC markedly enhanced the enzyme activity, and the Cat activity level increased to 36.87 ± 6.67 in serum and 3.54 ± 0.52 in brain tissue compared to the PD group (P = 0.003 in serum and P = 0.009 in tissue).